Spesolimab Clears Lesions in Generalized Pustular Psoriasis
In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions
By Physician’s Briefing Staff | December 27, 2021
In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions
By Physician’s Briefing Staff | December 27, 2021